(S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylic acid

We are (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylic acid CAS:1129634-44-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:   (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylic acid
CAS.NO:1129634-44-1
Synonyms:(6S)-5-[(2-methylpropan-2-yl)oxycarbonyl]-5-azaspiro[2.4]heptane-6-carboxylic acid

Molecular Formula: C12H19NO4
Molecular Weight:241.28400

Physical and Chemical Properties:
Density: 1.2±0.1 g/cm3
Boiling point: 377.4±35.0 °C at 760 mmHg
Melting point: /
Flash point: 182.1±25.9 °C
Refractive index: 1.536

Specification:
Appearance:Off-White Solid
Purity:≥99.0%
Identification:
A.H-NMR:Comply with the structure
B.LC-MS:Comply with the structure
C.The IR spectrum of sample should be identical with that of reference standard
Appearance:Meets the requirements.
HPLC:
Unspecified impurities: for each impurity :≤0.20%
Total Impurity:≤1.0%
Loss on drying:≤0.5%
Heavy metals:≤10 ppm
Water:≤1.0%

Packing:
 25kg / drum
Storage:Preserve in well-closed, light-resistant and airtight containers.
Application: Intermediates of Ledipasvir CAS:1256388-51-8

(S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylic acid


Related News: FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus.3-amino-4-clorobenzotrifluoruro CAS:121-50-6 FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus.Methyl 6-fluoro-1H-indole-4-carboxylate CAS:1082040-43-4 The CTSuccess service uses Catalent’s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics.6-Chloro-9-(tetrahydropyran-2-yl)purine CAS:7306-68-5 With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved.With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved.

Related Products
Product Name
(4R,5R)-3-oxo-2-oxabicyclo[2.2.1]heptane-5-carboxylic acid View Details
4-Chloropyrrolo[2,3-d]pyrimidine View Details
N2-(1-Oxohexadecyl)-L-lysyl-L-valyl-(2S)-2,4-diaminobutanoyl-L-threonine bis(trifluoroacetate) (salt) View Details
1,3-dicyclohexylcarbodiimide manufacturer Favipiravir manufacturer (2R,3S)-3-Phenylisoserine manufacturer 2-Bromo-5-fluorobenzotrifluoride manufacturer 1,2-Octanediol manufacturer